Professors Bokun Jang, Jungseon Kim, and Dongwook Kim Named Recipients of the 24th Pfizer Medical Award
Basic Medicine Award: Bokun Jang, Jeju National University
Clinical Medicine Award: Jungseon Kim, Yonsei University
Translational Medicine Award: Dongwook Kim, Yonsei University
Advances in Gastric Cancer Mechanisms, Antithrombotic Therapy for Atrial Fibrillation, and Cell Therapy Research for Parkinson’s Disease
The 24th Pfizer Medical Award, organized by the National Academy of Medicine of Korea and sponsored by Pfizer Korea, has named the following recipients: Professor Bokun Jang of the Department of Pathology at Jeju National University College of Medicine; Professor Jungseon Kim of the Division of Cardiology, Department of Internal Medicine at Yonsei University College of Medicine; and Professor Dongwook Kim of the Department of Physiology at Yonsei University College of Medicine.
Winners of the 24th Pfizer Medical Award. From the left, Professor Bo-Geun Jang of Jeju National University, Professor Joong-Sun Kim of Yonsei University, and Professor Dongwook Kim of Yonsei University. Pfizer Korea Pharmaceuticals
View original imageAccording to the National Academy of Medicine of Korea and Pfizer Korea on September 29, Professor Bokun Jang received the Basic Medicine Award in recognition of his research clarifying the biological characteristics of subtypes of gastric intestinal metaplasia and the mechanisms behind gastric cancer development. Professor Jang demonstrated that incomplete-type intestinal metaplasia is not simply a less differentiated state, but rather a unique condition possessing the identities of both gastric and intestinal epithelia, with distinct epigenetic properties compared to complete-type intestinal metaplasia.
Professor Jang validated his findings by generating organoids for each subtype of intestinal metaplasia derived from patient tissues, and by conducting spatial transcriptomics and epigenomics analyses. This research was published in the international journal Gut.
Professor Jungseon Kim, who received the Clinical Medicine Award, led a study to propose long-term antithrombotic therapy strategies for patients with atrial fibrillation who have reached a stable state after receiving drug-eluting stents. A randomized clinical trial involving 30 medical institutions in Korea demonstrated that, in patients who remained stable for more than one year after stent procedures, monotherapy with novel oral anticoagulants was clinically more advantageous than combination therapy with anticoagulants and antiplatelet agents. The research was published in the international journal The New England Journal of Medicine (NEJM).
Professor Dongwook Kim, recipient of the Translational Medicine Award, was recognized for extending research on Parkinson’s cell therapy into the clinical stage. Professor Kim developed a universal and highly efficient neural cell differentiation method as well as technology for suppressing tumorigenicity, and based on these advances, conducted clinical trials transplanting dopamine cells derived from embryonic stem cells into patients with Parkinson’s disease. The research team observed improvements in motor function and daily living ability after cell transplantation without serious safety issues. The results were published in the international journal Cell.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The awards ceremony for the 24th Pfizer Medical Award is scheduled to be held on November 4. Each recipient will receive a prize of KRW 50 million and a plaque for their respective category.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.